However, B cell frequencies are very low in the CNS and only the arrival of new and sensitive techniques, such as polymerase chain reaction (PCR), enabled the analysis of their maturation and developmental status. Earlier studies analysed the diversity of the third complementarity determining region (CDR3 gene fragments) of these CSF

B cells and found intrathecal expansion in MS patients. Furthermore, these compound screening assay B cells were T cell-dependent hypermutated post-germinal centre antibody-forming or memory cells that had been positively selected through their antigen receptor [19]. Interestingly, V(D)J genes utilized by peripheral and central B cells differed, which is indicative of compartmentalized clonal expansion [20]. Intensive analysis revealed

that CSF antibodies did not bind to myelin-basic protein (MBP), proteolipid protein (PLP) [17] or common viruses [21]; instead, some of them bound to targets on oligodendrocytes and astrocytes [22]. Somatic hypermutation of Ig transcripts in the CNS imply https://www.selleckchem.com/products/VX-765.html a local antigen-driven T cell-dependent process [23]. More recent studies showed that B cells are antigen-experienced, and identified different clonotypes in different plaques from the same individual [22]. Mutated B cells from MS lesions might sequentially colonize germinal centres (GC) in secondary lymphoid organs, undergo reactivation and then invade other Fossariinae brain regions. GC are the classic sites where mature B cells respond to antigen-bearing follicular dendritic cells (plus helper T cells), hypermutate their antibodies through somatic hypermutation and then migrate from the dark to the light zone, where they also class-switch and generate memory and plasma cells. In MS, clonally related B cells populate meninges, inflammatory lesions, normal appearing white matter and CSF and CNS-resident B cells shared between CSF and CNS produced antibodies, which can be detected in the CNS [24,25]. Indeed, there are follicle-like structures in the meninges in secondary progressive MS patients [13–15,26]

that have attracted much recent attention. If their suspected GC functions are confirmed, they may provide novel clues to the pathogenesis of MS. Another interesting line of investigation is the role of B cells as hosts for EBV. First isolated from Burkitt’s lymphomas in 1964 [27], its causal role in infectious mononucleosis (IM) was discovered by accident 4 years later. A laboratory technician working with lymphoma samples contracted EBV, seroconverted and developed IM. More than 90% of the population is infected with EBV by age of approximately 20 in Europe and much earlier in developing countries [28]. Whereas infection in childhood is mainly asymptomatic, the presentation is typical of IM in approximately half of first infections in young adults.